Literature DB >> 17071810

B-type natriuretic peptide in reversible myocardial ischaemia.

K Chatha1, M Alsoud, M J Griffiths, A Elfatih, K Abozguia, R C Horton, S J Dunmore, R Gama.   

Abstract

BACKGROUND: Coronary heart disease is associated with increased B-type natriuretic peptides (BNPs), and, although controversial, may cause exaggerated exercise-induced BNP secretion. We investigated BNP in relation to reversible myocardial ischaemia.
MATERIALS AND METHODS: Serum N-terminal proBNP (NT-proBNP) was measured before and after an exercise electrocardiogram test (ETT) in 14 patients with and 45 patients without exercise-induced myocardial ischaemia. Statistical analysis was carried out on logarithmically transformed data. Results, however, are pre-transformed data.
RESULTS: NT-proBNP increased with exercise both in ETT-positive patients (mean (SD) 71.4 (41.2) v 76.8 (44.0) ng/l; p<0.001) and ETT-negative patients (54.0 (61.2) v 60.1 (69.0) ng/l; p<0.001). Pre-exercise and post-exercise NT-proBNP were higher (p<0.05) in ETT-positive than in ETT-negative patients. Incremental NT-proBNP was similar in ETT-positive (4.7 (4.2) ng/l) and ETT-negative (6.2 (8.6) ng/l) patients.
CONCLUSION: Serum NT-proBNP concentrations are higher in patients with exercise-induced myocardial ischaemia than in those without. Exercise-induced electrocardiographic myocardial ischaemia, however, is not associated with exaggerated BNP secretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071810      PMCID: PMC1860506          DOI: 10.1136/jcp.2005.034702

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

Review 1.  Exercise tolerance testing.

Authors:  Jonathan Hill; Adam Timmis
Journal:  BMJ       Date:  2002-05-04

Review 2.  Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.

Authors:  Torbjørn Omland
Journal:  Scand J Clin Lab Invest Suppl       Date:  2005

3.  Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia.

Authors:  Htut Kyaw Win; Su-Min Chang; Michael Raizner; Gopi Shah; Faiz Al Basky; Unnati Desai; Juan Carlos Plana; John J Mahmarian; Miguel A Quinones; William A Zoghbi
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

Review 4.  The diagnostic and prognostic value of brain natriuretic peptide and aminoterminal (nt)-pro brain natriuretic peptide.

Authors:  Thomas Weber; Johann Auer; Bernd Eber
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

5.  B-type natriuretic peptide: a simple new test to identify coronary artery disease?

Authors:  A D Struthers; J Davies
Journal:  QJM       Date:  2005-08-08

Review 6.  Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia?

Authors:  Kiang-Teck J Yeo; Hong-Kee Lee; Kam-Cheong Wong; Robert S Foote
Journal:  J Card Fail       Date:  2005-06       Impact factor: 5.712

7.  Atrial and brain natriuretic peptide response to exercise in patients with ischaemic heart disease.

Authors:  S Nicholson; M Richards; E Espiner; G Nicholls; T Yandle
Journal:  Clin Exp Pharmacol Physiol       Date:  1993 Jul-Aug       Impact factor: 2.557

8.  N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.

Authors:  Michael Weber; Thorsten Dill; Roman Arnold; Matthias Rau; Okan Ekinci; Klaus D Müller; Alexander Berkovitsch; Veselin Mitrovic; Christian Hamm
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749

9.  Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris.

Authors:  K Marumoto; M Hamada; K Hiwada
Journal:  Clin Sci (Lond)       Date:  1995-05       Impact factor: 6.124

10.  Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.

Authors:  Ian Loke; Iain B Squire; Joan E Davies; Leong L Ng
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

View more
  1 in total

1.  Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia.

Authors:  M Başkurt; F Aktürk; K Keskin; P Canbolat; B Karadag; A Kaya; A Yildiz; U Coskun; K Kilickesmez; O Esen; S K Muniboglu
Journal:  Cardiovasc J Afr       Date:  2011 Mar-Apr       Impact factor: 1.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.